972
Views
45
CrossRef citations to date
0
Altmetric
Reviews

Psyllium Arabinoxylan: A Versatile Biomaterial for Potential Medicinal and Pharmaceutical Applications

, , &
Pages 1-30 | Received 10 Mar 2015, Accepted 15 Jul 2015, Published online: 13 Oct 2015

References

  • Rahn, K. “A phylogenetic study of the Plantaginaceae”, Bot. J. Linn. Soc. 1996, 120,145–198.
  • Ziai, S. A.; Larijani, B.; Akhoondzadeh, S.; Fakhrzadeh, H.; Dastpak, A.; Bandarian, F.; Rezai, A.; Badi, H. N.; Emamid, T. “Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients”, J. Ethnopharmacol. 2005, 102(2), 202–207.
  • Dhar, M. K.; Kaul, S.; Friebe, B.; Gill, B. S. “Chromosome identification in Plantago ovate Forsk through C-banding and FISH”, Curr. Sci. 2002, 83(2), 150–152.
  • Dagar, J. C.; Kumar, Y.; Tomar, O. S. “Cultivation of medicinal isabgol (Plantago ovata) in alkali soils in semiarid regions of Northern India”, Land Deg. Develop. 2006, 17(3), 275–283.
  • Samuelsen, A. B.; Lund, I.; Djahromi, J. M.; Paulsen, B. S.; Wold, L. K.; Knutsen, S. H. “Structural features and anticomplementary activity of some heteroxylan polysaccharide fractions from the seeds of Plantago major L.”, Carbohyd. Polym. 1999, 38(2), 133–143.
  • Washington, N.; Harris, M.; Mussellwhite, A.; Spiller, R. C. “Moderation of lactulose-induced diarrhea by psyllium: effects on motility and fermentation”, Am. J. Clin. Nutr. 1998, 67, 317–321.
  • Fischer, M. H.; Yu, N.; Gray, G. R.; Ralph, J.; Anderson, L.; Marlett, J. A. “The gel-forming polysaccharide of psyllium husk (Plantago ovata Forsk)”, Carbohyd. Res. 2004, 339, 2009–2017.
  • Srinivasan, R.; Agarwal, M.; Mishra, A. “Plantago psyllium-grafted-polyacrylonitrile-synthesis, characterization and its use in suspended and dissolved solid removal from textile effluent”, Water Qual. Res. J. Canada 2002, 37(2), 371–378.
  • Izydorczyk, M. S.; Biliaderis, C. G. “Cereal arabinoxylans: Advances in structure and physicochemical properties”, Carbohyd. Polym. 1995, 28(1), 33–48.
  • de Bock, M.; Derraik, J. G. B.; Brennan, C. M.; Biggs, J. B.; Smith, G. C.; Cameron-Smith, D.; Wall, C. R.; Cutfield, W. S. “Psyllium supplementation in adolescents improves fat distribution and lipid profile: A randomized, participant-blinded, placebo-controlled, crossover trial”, PLoS One 2012, 7(7), e41735–e71740.
  • Quitadamo, P.; Coccorullo, P.; Giannetti, E.; Romano, C.; Chiaro, A.; Campanozzi, A.; Poli, E.; Cucchiara, S.; Di Nardo, G.; Staiano, A. “A randomized, prospective, comparison study of a mixture of acacia fiber, psyllium fiber, and fructose vs polyethylene glycol 3350 with electrolytes for the treatment of chronic functional constipation in childhood”, J. Pediatr. 2012, 161(4), 710–715.
  • Feinglos, M. N.; Gibb, R. D.; Ramsey, D. L.; Surwit, R. S.; McRorie, J. W. “Psyllium improves glycemic control in patients with type-2 diabetes mellitus”, Bioactive Carbohyd. Diet. Fiber 2013, 1(2), 156–161.
  • Patil, B. S.; Mastiholimath, V. S.; Kulkarni A. R. “Development and evaluation psyllium seed husk polysaccharide based wound dressing films”, Orient. Pharm. Exp. Med. 2011, 11(2), 123–129.
  • Yadav, N.; Singh, N.; Siwach, P.; Yadav, O. P. “Nutraceutical composition of selected genotypes of Plantago ovata for vigorous genotype selection as health food”, Int. J. Plant Sci. 2006, 1(2), 167–171.
  • Cheng, Y.; Ohlsson, L.; Rui-Dong, D. “Psyllium and fat in diets differentially affect the activities and expressions of colonic sphingomyelinases and caspase in mice”, Brit. J. Nutr. 2004, 91, 715–723.
  • Foschia, M.; Peressini, D.; Sensidoni, A.; Brennan, M. A.; Brennan, C. S. “Synergistic effect of different dietary Fibers in pasta on in vitro starch digestion?”, Food Chem. 2015, 172(1), 245–250.
  • Iqbal, M. S.; Akbar, J.; Hussain, M. A.; Saghir, S.; Sher, M. “Evaluation of hot-water extracted arabinoxylans from ispaghula seeds as drug carriers”, Carbohyd. Polym. 2011, 83(3), 1218–1225.
  • Robert-Andersen, J.; Mehta, T.; Wilson, R.B. “Reduction of DMH-induced colon tumors in rats fed psyllium husk or cellulose”, Nutr. Cancer 1987, 10, 129–136.
  • Alabaster, O.; Tang, Z. C.; Frost, A.; Shivapurkar, N. “Potential synergism between wheat bran and psyllium: enhanced inhibition of colon cancer”, Cancer Lett. 1993, 75, 53–58.
  • Fernandez-Banares, F.; Hinojosa, J.; Sanchez-Lombrana, J. L.; Navarro, E.; Martinez-Salmeron, J. F.; Garcia-Puges, A.; Gonzalez-Huiz, F.; Riera, J.; Gonzalez-Lara, V.; Dominguez-Abascal, F.; Giné, J. J.; Moles, J.; Gomollón, F.; Gassull, M. A.“Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU)”, Am. J. Gastroenterol. 1999, 94, 427–433.
  • Anderson, J. W.; Hanna, T. J. “Impact of nondigestible carbohydrates on serum lipoproteins and risk for cardiovascular disease”, J. Nutr. 1999, 129, 1457S–1466S.
  • Gupta, R. R.; Argawal, C. G.; Singh, G. P.; Ghatak, A. “Lipid-lowering efficacy of psyllium hydrophilic mucilloid in non-insulin dependent diabetes mellitus with hypercholesterolemia”, Indian J. Med. Res. 1994, 100, 237–241.
  • Fukagawa, N. K.; Anderson, J. W.; Hageman, G.; Young, V. R.; Minaker, K. L. “High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults”, Am. J. Clin. Nutr. 1990, 52, 524–528.
  • Pastors, J. G.; Blaisdell, P. W.; Balm, T. K.; Asplin, C. M.; Pohl, S. L. “Psyllium fiber reduces rise in postprandial glucose and insulin concentrations in patients with non-insulin dependent diabetes”, Am. J. Clin. Nutr. 1991, 53, 1431–1435.
  • Rodriguez-Moran, M.; Guerrero-Romero, F.; Lazcano-Burciaga, G. “Lipid- and glucose-lowering efficacy of plantago psyllium in type II diabetes”, J. Diabetes Complications 1998, 12, 273–278.
  • Moreyra, A. E.; Wilson, A. C.; Koraym, A. “Effect of combining Psyllium fiber with simvastatin in lowering cholesterol”, Arch. Int. Med. 2005, 165, 1161–1166.
  • Romero, A. L.; West, K. L.; Zern, T.; Fernandez, M. L. The seeds from Plantago ovata lower plasma lipids by altering hepatic and bile acid metabolism in guinea pigs”, J. Nutr. 2002, 132, 1194–1198.
  • Anderson, J. W.; ỎNeal, D. S.; Riddell-Mason, S.; Floore, T. L.; Dillon, D. W.; Oeltgen, P. R. “Postprandial serum glucose, insulin, and lipoprotein responses to high- and low fiber diets”, Metabolism 1995, 44, 848–854.
  • Anderson, J. W.; Allgood, L. D.; Lawrence, A.; Altringer, L. A.; Jerdack, G. R.; Hengehold, D. A. “Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: meta-analysis of 8 controlled trials”, Am. J. Clin. Nutr. 2000, 71, 472–479.
  • Anderson, J. W.; Davidson, M. H.; Blonde, L. “Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia”, Am. J. Clin. Nutr. 2000, 71, 1433–1438.
  • Bouchoucha, M.; Faye, A.; Savarieau, B.; Arsac, M. “Effect of an oral bulking agent and a rectal laxative administered alone or in combination for the treatment of constipation”, Gastroenterol. Clin. Biol. 2004, 28, 438–443.
  • Ramkumar, D.; Rao, S. S. “Efficacy and safety of traditional medical therapies for chronic constipation: systematic review”, Am. J. Gastroenterol. 2005, 100, 936–971.
  • Pittler, M. H.; Ernst, E. “Dietary supplements for body-weight reduction: A systematic review”, Am. J. Clin. Nutr. 2004, 79, 529–536.
  • Raymundo, A.; Fradinho, P.; Nunes, M. C. “Effect of Psyllium Fiber content on the textural and rheological characteristics of biscuit and biscuit dough”, Bioactive Carbohyd. Diet. Fiber 2014, 3(2), 96–105.
  • Zandonadi, R. P.; Botelho, R. B. A.; Araújo, W. M. C. “Psyllium as a substitute for gluten in bread”, J. Am. Diet. Assoc. 2009, 109, 1781–1784.
  • Ahmadi, R.; Kalbasi-Ashtari, A.; Oromiehie, A.; Yarmand, M. S.; Jahandideh, F. “Development and characterization of a novel biodegradable edible film obtained from psyllium seed (Plantago ovata Forsk)”, J. Food Eng. 2012, 109(4), 745–751.
  • Sandhu, J S.; Hudson, G. J.; Kennedy, J. F. “The gel nature and structure of the carbohydrate of isapghula husk ex Plantago ovata Forsk”, Carbohyd. Res. 1981, 93, 247–259.
  • Mandal, K.; Saravanan, R.; Maiti, S.; Kothari, I. L. “Effect of downy mildew disease on photosynthesis and chlorophyll fluorescence in Plantago ovata Forsk”, J. Plant Dis. Prot. 2009, 116(4), 164–168.
  • Kennedy, J. F.; Sandhu, J. S.; Southgate, D. A. T. “Structural data for the carbohydrate of ispaghula husk ex Plantago ovata forsk”, Carbohyd. Res. 1979, 75, 265–274.
  • Guo, Q.; Cui, S. W.; Wang, Q.; Young, J. C. “Fractionation and physiochemical characterization of psyllium gum”, Carbohyd. Polym. 2008, 73(1), 35–43.
  • Saghir, S.; Iqbal, M. S.; Koschella, A.; Heinze, T. “Ethylation of arabinoxylan from Ispaghula (Plantago ovata) seed husk”, Carbohyd. Polym. 2009, 77(1), 125–130.
  • Chourasia, M. K.; Jain, S. K. “Pharmaceutical approaches to colon targeted drug delivery systems”, J. Pharm. Pharm. Sci. 2003, 6, 33–66.
  • Chourasia, M. K.; Jain, S. K. “Polysaccharides for colon targeted drug delivery”, Drug Deliv. 2004, 11, 129–148.
  • Desai, A.; Shidhaye, S.; Kadam, V. J. “Possible use of psyllium husk as a release retardant”, Int. J. Pharm. Sci. 2007, 69(2), 206–210.
  • Yasir, M.; Asif, M.; Bhattacharya, A.; Bajpai, M. “Development and evaluation of gastroretentive drug delivery system for theopylline using Psyllium husk”, Int. J. Chem. Technol. Res. 2010, 2(2), 792–799.
  • Kaialy, W.; Emami, P.; Asare-Addo, K.; Shojaee, S.; Nokhodchi, A. “Psyllium: a promising polymer for sustained release formulations in combination with HPMC polymers”, Pharm. Develop. Technol. 2014, 19(3), 269–277.
  • Belščak-Cvitanović, A.; Komes, D.; Karlović, S.; Djaković, S.; Špoljarić, I.; Mršić, G.; Ježek, D. “Improving the controlled delivery formulations of caffeine in alginate hydrogel beads combined with pectin, carrageenan, chitosan and psyllium”, Food Chem. 2015, 167(15), 378–386.
  • Garg, R.; Gupta, G. D. “Preparation and evaluation of gastroretentive floating tablets of silymarin”, Chem. Pharm. Bull. 2009, 57(6), 545–549.
  • Oda, Y.; Kamijyo, Y.; Okumura, T.; Tokuriki, Y.; Yamashita, J.; Handa, H.; Aoyama, I.; Hashi, K.; Mori, K. “Clinical application of a sustained release anticancer pellet”, No Shinkei Geka 1985, 13(12), 1305–1311.
  • Gnekow, A. K.; Kortmann, R. D.; Pietsch, T.; Emser, A. “Low grade chiasmatic hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy-report from the multicenter treatment study for children and adolescents with a low grade glioma -HIT-LGG 1996- of the Society of Pediatric Oncology and Hematology (GPOH)”, Klin. Padiatr. 2004, 216(6), 331–342.
  • Lin, Z.; Gao, W.; Hu, H.; Ma, K.; He, B.; Dai, W.; Wang, X.; Wang, J.; Zhang, X.; Zhang, Q. “Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity”, J. Control. Release 2014, 28(174), 161–170.
  • Singh, B.; Bala, R. “Polysaccharide based hydrogels as controlled drug delivery system for GIT cancer”, Int. J. Biol. Macromol. 2014, 65, 524–533.
  • Singh, B.; Lal, H.; Pal, L.; Sharma, V. “In vitro release profile of anti-ulcer drug rabeprazole from biocompatible psyllium-PVA hydrogels”, J. Mater. Sci. Mater. Med. 2012, 23(4), 1021–1032.
  • Singh, B.; Bala, R. “Design of dietary polysaccharide and binary monomer mixture of acrylamide and 2-acrylamido-2-methylpropane sulphonic acid based antiviral drug delivery devices”, Chem. Eng. Res. Design. 2012, 90(3), 346–358.
  • Svirskis, D.; Seyfoddin, A.; Chalabi, S.; In Kim, J. H.; Langford, C.; Painter, S.; Al-Kassas, R. “Development of mucoadhesive floating hollow beads of acyclovir with gastroretentive properties”, Pharm. Develop. Technol. 2014, 19(5), 571–576.
  • Kharia, A. A.; Hiremath, S. N.; Singhai, A. K.; Omray, L. K.; Jain, S. K. “Design and optimization of floating drug delivery system of acyclovir”, Indian J. Pharm. Sci. 2010, 72(5), 599–606.
  • Garg, R.; Gupta, G. D. “Preparation and evaluation of gastroretentive floating tablets of acyclovir”, Curr. Drug. Deliv. 2009, 6(5), 437–443.
  • Ram, H. N. A.; Lachake, P.; Kaushik, U.; Shreedhara, C. S. “Formulation and evaluation of floating tablets of liqourice extract”, Pharmacog. Res. 2010, 2(5), 304–308.
  • Chavanpatil, M. D.; Jain, P.; Chaudhari, S.; Shear, R.; Vavia, P. R. “Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation”, Int. J. Pharm. 2005, 304, 178–184.
  • Chavanpatil, M. D.; Jain, P.; Chaudhari, S.; Shear, R.; Vavia, P. R. “Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin”, Int. J. Pharm. 2006, 316, 86–92.
  • Asnaashari, S.; Khoei, N. S.; Zarrintan, M. H.; Adibkia, K.; Javadzadeh, Y. “Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets”, Pharm. Dev. Technol. 2011, 16(4), 400–407.
  • Choonara, Y. E.; Pillay, V.; Ndesendo, V. M.; du Toit, L. C.; Kumar, P.; Khan, R. A.; Murphy, C. S.; Jarvis, D. L. “Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers”, Colloid. Surf. B: Biointerf. 2011, 87(2), 243–254.
  • Chawla, R.; Jaiswal, S.; Mishra, B. “Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design”, Exp. Opin. Drug Deliv. 2014, 11(1), 31–43.
  • Udayakumar, T.; Vasudevan, M. “Novel sustained release swellable bioadhesive floating gastroretentive drug delivery system of bilayer tablets containing rifampicin and isoniazid”, Int. J. Pharm. Sci. Lett. 2012, 2(1), 21–24.
  • Li, L.; Sun, H.; Gao, J.; Jiang, T.; Gao, Y.; Zhang, J. “Optimization of sustained release matrix tablet of metoprolol succinate using central composite design”, Pak. J. Pharm. Sci. 2013, 26(5), 929–937.
  • Adibkia, K.; Ghanbarzadeh, S.; Mohammadi, G.; Khiavi, H. Z.; Sabzevari, A.; Barzegar-Jalali, M. “Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices”, Drug Res. (Stuttg). 2014, 64(3), 118–123.
  • Dey, S.; Chattopadhyay, S.; Mazumder, B. “Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release”, Biomed. Res. Int. 2014, 2014:396106. doi: 10.1155/2014/396106. Epub 2014 Jan 2.
  • Gohel, M. C.; Patel, M. M.; Amin, A. F. “Development of modified release diltiazem HCl tablets using composite index to identify optimal formulation”, Drug Develop. Ind. Pharm. 2003, 29(5), 565–574.
  • Negi, J. S.; Khanduri, P.; Trivedi, A.; Negi, V.; Singh, V. “Effect of psylium husk on floating behaviour of atenolol bilayer tablets”, Pharmacie Globale (IJCP) 2011, 4(6), 1–4.
  • Siahi-Shadbad, M. R.; Asare-Addo, K.; Azizian, K.; Hassanzadeh, D.; Nokhodchi, A. “Release behaviour of propranolol HCl from hydrophilic matrix tablets containing psyllium powder in combination with hydrophilic polymers”, AAPS Pharm. Sci. Technol. 2011, 12(4), 1176–1182.
  • Pawar, H.; Varkhade, C. “Isolation, characterization and investigation of Plantago ovata husk polysaccharide as superdisintegrant”, Int. J. Biol. Macromol. 2014, 69, 52–58.
  • Ngwuluka, N. C.; Choonara, Y. E.; Modi, G.; du Toit L. C.; Kumar, P.; Ndesendo, V. M.; Pillay, V. “Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease”, AAPS Pharm. Sci. Technol. 2013, 14(2), 605–619.
  • Kura, A. U.; Al Ali S. H. H.; Hussein, M. Z.; Fakurazi, S.; Arulselvan, P. “Development of a controlled-release anti-parkinsonian nano delivery system using levodopa as the active agent”, Int. J. Nanomed. 2013, 8, 1103–1110.
  • Garcia, J. J.; Fernandez, N.; Carriedo, D.; Diez, M. J.; Sahagun, A.; Gonzalez, A.; Calle, A.; Sierra, M. “Hydrosoluble fiber (Plantago ovata husk) and levodopa I: Experimental study of the pharmacokinetic interaction”, Eur. Neuropsychopharmacol. 2005, 15(5), 497–503.
  • Fernandez, N.; Carriedo, D.; Sierra, M.; Diez, M. J.; Sahagun, A.; Calle, A.; Gonzalez, A.; Garcia, J. J. “Hydrosoluble fiber (HYPERLINK "http://www.sciencedirect.com/science/article/pii/S0924977X05000374"Plantago ovata husk HYPERLINK "http://www.sciencedirect.com/science/article/pii/S0924977X05000374") and levodopa II: Experimental study of the pharmacokinetic interaction in the presence of carbidopa”, Eur. Neuropsychopharmacol. 2005, 15(5), 505–509.
  • Singh, B.; Chauhan, N. “Release dynamics of tyrosine from dietary fiber psyllium based hydrogels for use in Parkinson's disease”, Food Res. Int. 2010, 43(4), 1065–1072.
  • Bédouet, L.; Moine, L.; Pascale, F.; Nguyen, V. N.; Labarre, D.; Laurent, A. “Synthesis of hydrophilic intra-articular microspheres conjugated to ibuprofen and evaluation of anti-inflammatory activity on articular explants”, Int. J. Pharm. 2014, 459(1–2), 51–61.
  • Giri, T. K.; Thakur, D.; Alexander, A.; Badwaik, H. A.; Tripathy, M.; Tripathi, D. K. “Biodegradable IPN hydrogel beads of pectin and grafted alginate for controlled delivery of diclofenac sodium”, J. Mater. Sci. Mater. Med. 2013, 24(5), 1179–1190.
  • Cheng, Y. H.; Yang, S. H.; Liu, C. C.; Gefen, A.; Lin, F. H. “Thermosensitive hydrogel made of ferulic acid-gelatin and chitosan glycerophosphate”, Carbohyd. Polym. 2013, 92(2), 1512–1519.
  • Sujja-areevath, J.; Munday, D. L.; Cox, P. J.; Khan, K. A. “Release characteristics of diclofenac sodium from encapsulated natural gum mini-matrix formulations”, Int. J. Pharmaceut. 1996, 139, 53–62.
  • Bhatia, M.; Ahuja, M. “Psyllium arabinoxylan: carboxymethylation, characterization and evaluation for nanoparticulate drug delivery”, Int. J. Biol. Macromol. 2015, 72, 495–501.
  • Rosu, M. C.; Bratu, L. “Promising psyllium-based composite containing TiO2 nanoparticles as aspirin-carrier matrix”, Prog. Natl. Sci.: Mater. Int. 2014, 24(3), 205–209.
  • An, J.; Wang, W.; Wang, A. “Preparation and swelling behavior of a pH-responsive psyllium-g-poly(acrylic  acid) attapulgite superabsorbent nanocomposite”, Int. J. Polym. Mater. Polym. Biomater. 2012, 61(12) 906–918.
  • Liu, W.; Xie, Z.; Zhang, B.; Wang, Q.; Yao, W.; Gao, X.; Yu, L. L. “Effects of hydroxypropylation on the functional properties of psyllium”, J. Agric. Food Chem. 2010, 58(3), 1615–1621.
  • Yu, L. L.; Perret J. “Effects of xylanase treatments on gelling and water-uptaking properties of psyllium”, J. Agric. Food Chem. 2003, 51(2), 492–495.
  • Allen, K. G. D.; Bristow, S. J.; Yu, L. “Hypolipidemic effects of modified psyllium preparations”, J. Agric. Food Chem. 2004, 52(16), 4998–5003.
  • Liu, W.; Zhang, B.; Wang, Q.; Xie, Z.; Yao, W.; Gao, X.; Yu, L. L. “Effects of sulfation on the physicochemical and functional properties of psyllium”, J. Agric. Food Chem. 2010, 58(1), 172–179.
  • Siepmann, J.; Peppas, N. A. “Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)”, Adv. Drug Deliv. Rev. 2001, 48(2–3), 139–157.
  • Roy, D. S.; Rohera, B. D. “Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices”, Eur. J. Pharm. Sci. 2002, 16(3), 193–199.
  • Saghir, S.; Iqbal, M. S.; Hussain, M. A.; Koschella, A.; Heinze, T. “Structure characterization and carboxymethylation of arabinoxylan isolated from Ispaghula (Plantago ovata) seed husk”, Carbohyd. Res. 2008, 74(2), 309–317.
  • Niu, Y.; Xie, Z.; Hao, J.; Yao, W.; Yue, J.; Yu, L. L. “Preparation of succinylated derivatives of psyllium and their physicochemical and bile acid-binding properties”, Food Chem. 2012, 132(2), 1025–1032.
  • Singh, B.; Bala, R. “Design of radiation crosslinked psyllium and binary monomers-based hydrogels for use in colon drug delivery”, Int. J. Polym. Mater. Po. 2013, 62(2), 68–75.
  • Mishra, S.; Sinha, S.; Dey, K. P.; Sen, G. “Synthesis, characterization and applications of polymethylmethacrylate grafted psyllium as flocculant”, Carbohyd. Polym. 2014, 99(2), 462–468.
  • Singh, B.; Chauhan, G. S.; Sharma, D. K.; Kant, A.; Gupta, I.; Chauhan, N. “The release dynamics of model drugs from the psyllium and N-hydroxymethylacrylamide based hydrogels”, Int. J. Pharm. 2006, 325, 15–25.
  • Singh, B.; Chauhan, G. S.; Sharma, D. K.; Chauhan, N. “The release dynamics of salicylic acid and tetracycline hydrochloride from the psyllium and polyacrylamide based hydrogels (II)”, Carbohyd. Polym. 2007, 67, 559–565.
  • Kaith, B. S.; Kumar, K. “In air synthesis of Psy-cl-poly(AAm) network and its application in water-absorption from oil-water emulsions”, eXPRESS Polym. Lett. 2007, 1(7), 474–480.
  • Kaith, B. S.; Kumar, K. “Preparation of Psyllium mucilage and acrylic acid based hydrogels and their application in selective absorption of water from different oil/water emulsions”, Iran. Polym. J. 2007, 16(8), 529–538.
  • Mishra, A.; Agarwal, M.; Bajpai, M.; Rajani, S.; Mishra, R. P. “Plantago Psyllium mucilage for sewage and tannery effluent treatment”, Iran. Polym. J. 2002, 11(6), 381–386.
  • Agarwal, M.; Rajani, S.; Mishra, A. “Study of flocculation efficiency of Okra gum in sewage waste water”, Macromol. Mater. Eng. 2001, 286(9), 560–563.
  • Sen, G.; Mishra, S.; Rani, G. U.; Rani, P.; Prasad, R. “Microwave initiated synthesis of polyacrylamide grafted Psyllium and its application as a flocculant”, Int. J. Biol. Macromol. 2012, 50(2), 369–375.
  • Kumar, R.; Sharma, K.; Tiwary, K. P.; Sen, G. “Polymethacrylic acid grafted psyllium (Psy-g-PMA): a novel material for waste water treatment”, Appl. Water Sci. 2013, 3(1), 285–291.
  • Kumar, K.; Kaith, B. S.; Jindal, R.; Mittal, H. “Gamma-radiation initiated synthesis of Psyllium and acrylic acid-based polymeric networks for selective absorption of water from different oil-water emulsions”, J. Appl. Polym. Sci. 2012, 124(6), 4969–4977.
  • Rosamond, W. D.; Cahambless, L. E.; Folsom, A. R.; Cooper, L. S.; Conwill, J. E.; Clegg, L.; Wang, C. H.; Heiss, G. “Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to1994”, New Eng. J. Med. 1998, 339, 861–867.
  • Castelli, W. P. “Cholesterol and lipids in the risk of coronary heart disease: The Framingham Heart Study”, Can. J. Cardiol. 1988, 4, 5A–10A.
  • Popkin, B. M. “The nutrition transition and obesity in the developing world”, J. Nutr. 2001, 131, 871S–873S.
  • Isomaa, B.; Almgren, P.; Tuomi, T.; Forsén, B.; Lahti, K.; Nissén, M.; Taskinen, M. R.; Groop, L. “Cardiovascular morbidity and mortality associated with the metabolic syndrome”, Diabetes Care 2001, 24, 683–689.
  • Grundy, S. M. “Obesity, metabolic syndrome, and cardiovascular disease”, J. Clin. Endocrinol. Metab. 2004, 89, 2595–2600.
  • Liu, S.; Stampfer, M. J.; Hu, F. B.; Giovannucci, E.; Rimm, E.; Manson, J. E.; Hennekens, C. H.; Willett, W. C. “Whole grain consumption and risk of coronary heart disease: Results from the Nurses' Health Study”, Am. J. Clin. Nutr. 1999, 70, 412–419.
  • Davidson, M. H.; Dugan, L. D.; Burns, J. H. “A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: A controlled, double-blind, crossover study”, Am. J. Clin. Nutr. 1996, 63, 96–102.
  • Florholmen, J.; Arvidsson-Lenner, R.; Jorde, R.; Burhol, P .G. “The effect of metamucil on postprandial blood glucose and plasma gastric inhibitory peptide in insulin-dependent diabetics”, Acta Med. Scand. 1982, 212, 237–239.
  • Anonymous. “Health claims: soluble fiber from certain foods and risk of coronary heart disease (CHD) In: Code of Federal Regulations, pp. 442–446. Food and Drug Administration Department of Health and Human Services, Washington, D.C., USA. Retrieved November 28, 2007 from, http://www.access.gpo.gov/nara/cfr/waisidx_07/ 21cfr101_07.html.
  • Cicero, A. F. G.; Derosa, G.; Manca, M.; Bove, M.; Borghi, C.; Gaddi, A. V. “Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: A six-month, randomized clinical trial”, Clin. Exp. Hypertens. 2007, 29(6), 383–394.
  • Cicero, A. F. G.; Derosa, G.; Bove, M.; Imola, F.; Borghi, C.; Gaddi, A. V. “Psyllium improves dyslipidaemia, hyperglycaemia and hypertension, while guar gum reduces body weight more rapidly in patients affected by metabolic syndrome following an AHA Step 2 diet”, Mediterranean J. Nutr. Metab. 2010, 3(1), 47–54.
  • Hasler, C. M.; Kundrat, S.; Wool, D. “Functional foods and cardiovascular disease”, Curr. Atherosclerosis Rep. 2000, 2(6), 467–475.
  • Vega-Lόpez, S.; Vidal-Quintanar, R. L.; Fernandez, M. L. “Sex and hormonal status influence plasma lipid responses to psyllium”, Am. J. Clin. Nutr. 2001, 74, 435–441.
  • Brown, L.; Rosner, B.; Willett, W.; Sacks, F. “Cholesterol-lowering effects of dietary fiber: A meta-analysis”, Am. J. Clin. Nutr. 1999, 69, 30–42.
  • Gelissen, I. C.; Brodie, B.; Eastwood, M. A. “Effect of Plantago ovata (psyllium) husk and seeds on sterol metabolism: Studies in normal and ileostomy subjects”, Am. J. Clin. Nutr. 1994, 59, 395–400.
  • Marlett, J. A.; Fischer, M. H. “The active fraction of psyllium seed husk”, Proc. Nutr. Soc. 2003, 62, 207–209.
  • Marlett, J. A.; Fischer, M. H. “A poorly fermented gel from psyllium seed husk increases excreta moisture and bile acid excretion in rats”, J. Nutr. 2002, 132, 2638–2643.
  • Pal, S.; Khossousi, A.; Binns, C.; Dhaliwal, S.; Radavelli-Bagatini, S. “The effects of 12-week psyllium Fiber supplementation or healthy diet on blood pressure and arterial stiffness in overweight and obese individuals”, The Brit. J. Nutr. 2012, 107(5), 725–734.
  • Aranda, J. B.; Contreras, F.; Bagchi, D.; Preuss, H. G. “Efficacy of a novel chitosan formulation on fecal fat excretion: A double-blind, crossover, placebo-controlled study”, J. Med. 2002, 33(1–4), 209–225.
  • Daggy, B. P.; ỎConnell, N. C.; Jerdack, G. R.; Stinson, B. A; Setchell, R. D. R. “Additive hypocholesterolemic effect of psyllium and cholestyramine in the hamster: Effect on fecal sterol and bile acid profiles”, J. Lipid Res. 1997, 38, 491–502.
  • Olson, B. H.; Anderson, M. S.; Becker, M. P.; Anderson, J. W.; Hunninghake, D. B.; Jenkins, D. J. A.; LaRosa, J. C.; Rippe, J. M.; Roberts, D. C. K.; Stoy, D. B.; Summerbell, C. D.; Truswell, A. S.; Wolever, T. M. M.; Morris, D. H.; Fulgoni, V. L. “Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: Results of a meta-analysis”, J. Nutr. 1997, 127, 1973–1980.
  • Trautwein, E. K.; Kunath-Rau, A.; Erbersdobler, H. F. “Increased fecal bile acid excretion and changes in the circulating bile acid pool are involved in the hypocholesterolemic and gallstone-preventive actions of psyllium in hamsters”, J. Nutr. 1999, 129, 896–902.
  • Vega-Lόpez, S.; Freake, H. C.; Fernandez, M. L. “Sex and hormonal status modulate the effects of psyllium on plasma lipids and monocyte gene expression in humans”, J. Nutr. 2003, 133, 67–70.
  • Uehleke, B.; Ortiz, M.; Stange, R. “Cholesterol reduction using psyllium husks-Do gastrointestinal adverse effects limit compliance? Results of a specific observational study”, Phytomedicine 2008, 15(3), 153–159.
  • Wei, Z. H.; Wang, H.; Chen, X. Y.; Wang, B. S.; Rong, Z. X.; Wang, B. S.; Su, B. H.; Chen, H. Z. “Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials”, Eur. J. Clin. Nutr. 2009, 63, 821–827.
  • Solà, R.; Godàs, G.; Ribalta, J.; Vallvé, J. C.; Girona, J.; Anguera, A.; Ostos, M.; Recalde, D.; Salazar, J.; Caslake, M.; Martín-Luján, F.; Salas-Salvadó, J.; Masana, L. “Effects of soluble fiber (Plantago ovatahusk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease1‘2’3”, Am. J. Clin. Nutr. 2007, 85(4), 1157–1163.
  • McCall, M. R.; Mehta, T.; Leathers, C. W.; Foster, D. M. “Psyllium husk I: effect on plasma lipoproteins, cholesterol metabolism and atherosclerosis in African green monkeys”, Am. J. Clin. Nutr. 1992, 56, 376–384.
  • McCall, M. R.; Mehta, T.; Leathers, C. W.; Foster, D. M. “Psyllium husk II: Effect on the metabolism of apolipoprotein B in African green monkeys”, Am. J. Clin. Nutr. 1992, 56, 385–393.
  • Davidson, M. H.; Maki, K. C.; Kong, J. C.; Dugan, L. D.; Torri, S. A.; Hall, H. A.; Drennan, K. B.; Anderson, S. M.; Fulgoni, V. L.; Saldanha, L. G.; Olson, B. H. “Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia”, Am. J. Clin. Nutr. 1998, 67, 367–376.
  • Abraham, Z. D.; Mehta, T. “Three-week psyllium-husk supplementation: effect on plasma cholesterol concentrations, fecal steroid excretion, and carbohydrate absorption in men”, Am. J. Clin. Nutr. 1988, 47, 67–74.
  • Everson, G. T.; Daggy, B. P.; McKinley, C.; Story, J. A. “Effects of psyllium hydrophilic mucilloid on LDL-cholesterol and bile acid synthesis in hypercholesterolemic men”, J. Lipid Res. 1992, 33, 1183–1192.
  • Fernandez, M. L.; Ruiz, L. R.; Conde, A. K.; Sun, D. M.; Erickson, S. K.; McNamara, D. J. “Psyllium reduces plasma LDL in guinea pigs by altering hepatic cholesterol homeostasis”, J. Lipid Res. 1995, 36, 1128–1138.
  • Fernandez, M. L. “Distinct mechanism of plasma LDL lowering by dietary fiber in the guinea pig: specific effects of pectin, guar gum, and psyllium”, J. Lipid Res. 1995, 36, 2394–2404.
  • Haskell, W. L.; Spiller, G. A.; Jensen, C. D.; Ellis, B. K.; Gates, J. E. “Role of water-soluble dietary fiber in the management of elevated plasma cholesterol in healthy subjects”, Am. J. Cardiol. 1992, 69(5), 433–439.
  • Galisteo, M.; Sánchez, M.; Vera, R.; González, M.; Anguera, A.; Duarte, J.; Zarzuelo, A. “A diet supplemented with husks of Plantago ovate reduces the development of endothelial dysfunction, hypertension, and obesity by affecting adiponectin and TNF-in obese Zucker rats”, J. Nutr. 2005, 135, 2399–2404.
  • Chan, M. Y.; Heng, C. K. “Sequential effects of a high-fiber diet with psyllium husks on the expression levels of hepatic genes and plasma lipids”, Nutrition 2008, 24(1), 57–66.
  • Bernstein, A. M.; Titgemeier, B.; Kirkpatrick, K.; Golubic, M.; Roizen, M. F. “Major cereal grain fibers and psyllium in relation to cardiovascular health”, Nutrients 2013, 5(5), 1471–1487.
  • Gilani, A. H.; Rahman, A. “Trends in ethnopharmacology”, J. Ethnopharmacol. 2005, 100(1–2) 43–49.
  • Ouyang, H.; Chen, J. D. “Therapeutic role of acu-puncture in functional gastrointestinal disorders”, Aliment. Pharmacol. Ther. 2004, 20, 831–841.
  • Cheng, C. W.; Bian, Z. X.; Wu, T. X. “Systemic review of Chinese herbal medicine for functional constipation”, World J. Gastroenterol. 2009, 15, 4886–4895.
  • Gilani, A. H. “Constipation and its treatment with natural drugs used in Pakistan. In: Natural Drugs and the Digestive Tract; Capasso F, Mascolo N, eds.; EMSI: Rome, 1992, 117–121.
  • Pasricha, P. J. “Treatment of disorders of bowel motility and water flux. In: The Pharmacological Basis of Therapeutics; Brunton, L. L.; Lazo, J. S.; Parker, K. L, eds.; 11th ed.; McGraw-Hill: NY, 2006, pp. 983–1008.
  • Cummings, J. H. The effect of dietary fiber on fecal weight and composition. In: Dietary Fiber in Human Nutrition; Spiller, G. A., ed. CRC Press: Boca Raton, FL, 1993, pp. 263–350.
  • Spiller, G. A.; Shipley, E. A.; Chernoff, M. C.; Cooper, W. C. “Bulk laxative efficacy of a psyllium seed hydrocolloid and of a mixture of cellulose and pectin”, J. Clin. Pharmacol. 1979, 19, 313–320.
  • Stevens, J.; VanSoest, P. J.; Robertson, J. B.; Levitsky, D. A. “Comparison of the effects of psyllium and wheat bran on gastrointestinal transit time and stool characteristics”, J. Am. Diet. Assoc. 1988, 88, 323–326.
  • Marteau, P.; Flourié, B.; Cherbut, C.; Corréze, J. L.; Pellier, P.; Seylaz, J.; Rambaud, J. C. “Digestibility and bulking effect of ispaghula husks in healthy humans”, Gut 1994, 35, 1747–1752.
  • Marlett, J. A.; Kajs, T. M.; Fischer, M. H. “An unfermented gel component of psyllium seed husk promotes laxation as a lubricant in humans”, Am. J. Clin. Nutr. 2000, 72, 784–789.
  • Mehmood, M.; Aziz, N.; Ghayur, M.; Gilani, A. “Pharmacological basis for the medicinal use of psyllium husk (ispaghula) in constipation and diarrhea”, Digestive Dis. Sci. 2011, 56(5), 1460–1471.
  • Mcrorie, J. W.; Daggy, B. P.; Morel, J. G.; Diersing, P. S.; Miner, B. P.; Robinson, M. “Psyllium is superior to docusate sodium for treatment of chronic constipation”, Aliment. Pharmacol. Ther. 1998, 12, 491–497.
  • Dettmar, P. W.; Sykes, J. “A multi-centre, general practice comparison of ispaghula husk with lactulose and other laxatives in the treatment of simple constipation”, Curr. Med. Res. Opin. 1998, 14(4), 227–233.
  • Wang, H. J.; Liang, X. M.; Yu, Z. L.; Zhou, L. Y.; Lin, S. R.; Geraint, M. “A randomised, controlled comparison of low-dose polyethylene Glycol 3350 plus electrolytes with ispaghula husk in the treatment of adults with chronic functional constipation”, Clin. Drug Inves. 2004, 24(10), 569–576.
  • Freiche, V.; Houston, D.; Weese, H.; Evason, M.; Deswarte, G.; Ettinger, G.; Soulard, Y.; Biourge, V.; German, A. J. “Uncontrolled study assessing the impact of a pysllium-enriched extruded dry diet on faecal consistency in cats with constipation”, J. Feline Med. Surg. 2011, 13(12), 903–911.
  • Wolff, S. P. “Diabetes mellitus and free radicals”, Brit. Med. Bull. 1993, 49, 642–652.
  • Robert, A.; Wenatchee, W. A.; Tallahassee, F. L.; Lynn, S. R. “Association of diabetes with genetic and environmental factors, University of Maryland Medical Center”, Diabetes 1999, 18, 446–452.
  • Guthrie, D. W.; Guthrie, R. A. “Pathophysiology of Diabetes mellitus” Crit. Care Nurs. Q. 2004, 27(2), 113–125.
  • Ahmed, I.; Naeem, M.; Shakoor, A.; Ahmed, Z.; Iqbal, H. M. N. “Investigation of anti-diabetic and hypocholesterolemic potential of Psyllium husk fiber (Plantago psyllium) in diabetic and hypercholesterolemic albino rats”, World Acad. Sci. Eng. Technol. 2010, 37, 1229–1233.
  • Ziai, S. A.; Larijani, B.; Fakhrzadeh, H.; Dastpak, A.; Bandarian, F.; Rezai, A. “Study of Psyllium (Plantago ovata L.) effects on diabetes and lipidemia in the Iranian type II diabetic patients”, J. Med. Plant 2004, 3, 41–50.
  • Moreaux, S. J. J.; Nichols, J. L.; Bowman, J. G. P.; Hatfield, P. G. “Psyllium lowers blood glucose and insulin concentrations in horses”, J. Equine Vet. Sci. 2011, 31(4), I 160–165.
  • Tack, J.; Müller-Lissner S. “Treatment of chronic constipation: Current pharmacologic approaches and future directions”, Clin. Gastroenterol. Hepatol. 2009, 7, 502–508.
  • Nemes, Z. “Diarrhea from the infectologist's point of view”, OrvHetil. 2009, 150, 353–361.
  • Kosek, M.; Bern, C.; Guerrant, R. L. “The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000”, Bull. World Health Organ. 2003, 81, 197–204.
  • Liebelt, E. L. “Clinical and laboratory evaluation and management of children with vomiting and dehydration”, Curr. Opin. Pediatr. 1998, 10, 461–469.
  • WHO. “Diarrhoea: Why children are still dying and what can be done?” Geneva: World Health Organization; 2009.
  • Qvitzau, S.; Matzen, P.; Madsen, P. “Treatment of chronic diarrhoea: loperamide versus ispaghula husk and calcium”, Scand. J. Gastroenterol. 1988, 23, 1237–1240.
  • Belknap, D.; Davidson, L. J.; Smith, C. R. “The effects of Psyllium hydrophilic mucilloid on diarrhea in enterally fed patients”, Heart Lung. 1997, 26, 229–237.
  • Rachlis, A.; Gill, J.; Baril, J. G.; LeBlanc, R. P.; Trottier, B.; MacLeod, J.; Walmsley, S.; Van derVliet, W.; Belsky, G.; Burgoyne, R. “Effectiveness of step-wise intervention plan for managing nelfinavir-associated diarrhea: a pilot study”, HIV Clin. Trials 2005, 6, 203–212.
  • Cannon, S. J.; Fahey Jr. G. C.; Murphy, M. R.; Dikeman, C. L.; Miller, B. L.; Drackley, J. K. “Inclusion of psyllium in milk replacer for neonatal calves. 1. Effects on growth, digesta viscosity, rate of passage, nutrient digestibilities, and metabolites in blood”, J. Dairy Sci. 2010, 93(8), 3652–3660.
  • Cannon, S. J.; Fahey Jr. G. C.; Pope, L. L.; Bauer, L. L.; Wallace, R. L.; Miller, B. L.; Drackley, J. K. “Inclusion of psyllium in milk replacer for neonatal calves. 2. Effects on volatile fatty acid concentrations, microbial populations, and gastrointestinal tract size”, J. Dairy Sci. 2010, 93(10), 4744–4758.
  • Landes, A. D.; Hassel, D. M.; Funk, J. D.; Hill, A. “Fecal sand clearance is enhanced with a product combining probiotics, prebiotics, and psyllium in clinically normal horses”, J. Equine Vet. Sci. 2008, 28(2), 79–84.
  • Chomchai, C.; Bhadrachari, N.; Nigro, N. D. “The effect of bile on the induction of experimental intestinal tumors in rats”, Dis. Colon Rectum 1974, 17, 310–312.
  • Narisawa, T.; Magadia, N. E.; Weisburger, J. H.; Wynder, E. L. “Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N9-nitro-N-nitrosoguanidine in rats”, J. Natl. Cancer Inst. 1974, 53, 1093–1097.
  • Liu, K.; Stamler, J.; Moss, D.; Garside, D.; Persky, V.; Soltero, I. “Dietary cholesterol, fat, and Fiber, and colon-cancer mortality: An analysis of international data”, Lancet 1979, 2, 782–785.
  • Pisani, P.; Parkin, D. M.; Bray, F.; Ferlay, J. “Estimates of the worldwide mortality from 25 cancers in 1990”, Int. J. Cancer 1999, 83, 18–29.
  • Morita, T.; Kasaoka, S.; Oh-Hashi, A.; Ikai, M.; Numasaki, Y.; Kiriyama, S., Resistant proteins alter cecal short-chain fatty acid profiles in rats fed high amylose corn starch”, J. Nutr. 1998, 128, 1156–1164.
  • Tengku, S. A.; Norhayati, M. “Public health and clinical importance of amoebiasis in Malaysia: A review”, Trop. Biomed. 2011, 28(2), 194–222.
  • Zaman, A.; Manzoor, S. M.; Zaki, M.; Aziz, N.; Gilani, A. H. “The presence of antiamoebic constituents in Psyllium husk”, Phytother. Res. 2002, 16(1), 78–79.
  • Cappa, C.; Lucisano, M.; Mariotti, M. “Influence of Psyllium, sugar beet Fiber and water on gluten-free dough properties and bread quality”, Carbohyd. Polym. 2013, 98(2), 1657–1666.
  • Kecmanovic, D. M.; Pavlov, M. J.; Ceranic, M. S.; Kerkez, M. D.; Rankovic, V. I.; Masirevic, V. P. “Bulk agent Plantago ovata after Milligan-Morgan hemorrhoidectomy with Ligasure™”, Phytother. Res. 2006, 20(8), 655–658.
  • Luccia, B. H. D.; Kunkel, M. E. “In vitro availability of calcium from sources of cellulose, methylcellulose, and psyllium”, Food Chem. 2002, 77(2), 139–146.
  • Luccia, H. D.; Kunkel, M. E. “Psyllium reduces relative calcium bioavailability and induces negative changes in bone composition in weanling Wistar rats”, Nutr. Res. 2002, 22(9), 1027–1040.
  • Asvarujanon, P.; Ishizuka, S.; Hara, H. “Inhibitory effects of Psyllium on rat mineral absorption were abolished by reduction of viscosity with partial hydrolysis”, Biosci. Biotechnol. Biochem. 2004, 68(8), 1737–1742.
  • Samantaroy, S.; Mohanty, A. K.; Misra M. “Removal of hexavalent chromium by Kendu fruit gum dust”, J. Appl. Polym. Sci. 1997, 66, 1485–1494.
  • Khalil, M. I.; Farag, S. “Utilization of some starch derivatives in heavy metal ion removal”, J. Appl. Polym. Sci. 1998, 69, 45–50.
  • Udaybhaskar, P.; Iyengar, L.; Rao, A. V. S. P. “Hexavalent chromium interaction with chitosan”, J. Appl. Polym. Sci. 1990, 39, 739–747.
  • Sanghi, R.; Bhattacharya, B. “Comparative evaluation of natural polyelectrolytes psyllium and chitosan as coagulant aids for decolourization of dye solutions”, Water Qual. Res. J. Canada 2005, 40 (1), 97–101.
  • Al-Hamadani, Y. A. J.; Yusoff, M. S.; Umar, M.; Bashir, M. J. K.; Adlan, M. N. “Application of psyllium husk as coagulant and coagulant aid in semi-aerobic landfill leachate treatment”, J. Hazard. Mater. 2011, 190(1–3), 582–587.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.